MYC and neoplasm: Our results implied that the m6A-C1 was classified through multiple tumor-related biological processes (angiogenesis, EMT and hypoxia) and biomarkers (MYC and E2F); m6A-C2 was classified through several pathways correlated with tumorigenesis and progression, such as Wnt, TGF-beta and Notch pathways.